Insurancenewsnet.com

New Hormones Study Findings Have Been Reported by Researchers at University of Michigan (Understanding Insurance Coverage Policies for Incretin Mimetics for Weight Management ...

2025 AUG 21 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- Researchers detail new data in Drugs and Therapies - Hormones. According to news originating from Ann Arbor, ...
Yahoo

Zepbound vs. Wegovy: Comparing weight loss drugs

Zepbound (tirzepatide) and Wegovy (semaglutide) are FDA-approved injectable medications revolutionizing weight management. Both belong to the incretin mimetic drug class but differ in their mechanisms ...
The American Journal of Managed Care

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care. Their qualitative study, "Understanding ...
Staten Island Advance

Are prescription weight-loss drugs like Ozempic, Wegovy for you? Staten Island doctors talk pros, cons

STATEN ISLAND, N.Y. — Staten Island has the second-highest obesity rate in New York City, so it’s no surprise that interest in revolutionary new obesity drugs like Ozempic and Wegovy is skyrocketing ...